Title: The Role of the Advanced Lung Cancer Inflammation Index (ALI) in the Risk of
Liver Fibrosis and Mortality Among US Adult MAFLD Patients: A Cross-Sectional Study of
NHANES 1999–2018
Version: 3 Date: 09 Feb 2025
Reviewer's report:
Given the updated definition of MASLD (Metabolic Associated Steatotic Liver Disease),
the entire analysis would indeed need to be revisited. This change may have implications
for the diagnostic criteria and risk factors associated with the condition, which would affect
the study's results and conclusions. It would be important for the authors to update their
definitions, methods, and interpretations accordingly to align with the new terminology and
clinical understanding. Revisiting the relationship between ALI and MASLD using the updated
framework would strengthen the manuscript and ensure its relevance in light of the new
definition.
Title: The Role of the Advanced Lung Cancer Inflammation Index (ALI) in the Risk of
Liver Fibrosis and Mortality Among US Adult MAFLD Patients: A Cross-Sectional Study of
NHANES 1999–2018
Version: 3 Date: 09 Feb 2025
Reviewer's report:
Given the updated definition of MASLD (Metabolic Associated Steatotic Liver Disease),
the entire analysis would indeed need to be revisited. This change may have implications
for the diagnostic criteria and risk factors associated with the condition, which would affect
the study's results and conclusions. It would be important for the authors to update their
definitions, methods, and interpretations accordingly to align with the new terminology and
clinical understanding. Revisiting the relationship between ALI and MASLD using the updated
framework would strengthen the manuscript and ensure its relevance in light of the new
definition.
Please review this paper.
user
Title: The Role of the Advanced Lung Cancer Inflammation Index (ALI) in the Risk of
Liver Fibrosis and Mortality Among US Adult MAFLD Patients: A Cross-Sectional Study of
NHANES 1999–2018
Version: 3 Date: 09 Feb 2025
Reviewer's report:
Given the updated definition of MASLD (Metabolic Associated Steatotic Liver Disease),
the entire analysis would indeed need to be revisited. This change may have implications
for the diagnostic criteria and risk factors associated with the condition, which would affect
the study's results and conclusions. It would be important for the authors to update their
definitions, methods, and interpretations accordingly to align with the new terminology and
clinical understanding. Revisiting the relationship between ALI and MASLD using the updated
framework would strengthen the manuscript and ensure its relevance in light of the new
definition.
assistant